Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma

Cancer

Volumn 97, Issue 9, 2003, Pages 2196-2202

  Farley, John H ^a   Hickey, Kimberly W ^a   Carlson, Jay W ^b   Rose, G Scott ^b   Kost, Edward R ^c   Harrison, Terry A ^d  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Adenosquamous; Carcinoma; Cervix; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; UNITED STATES; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOSQUAMOUS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0037403437     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11371     Document Type: Article

References (23)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol. 2000;78:97-105.
3. Lea JS, Sheets EE, Wenham RM, et al. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival. Gynecol Oncol. 2002;84:115-119.
4. Alfsen GC, Kristensen GB, Skovlund E, Pettersen EO, Abeler VM. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer. 2001;92:2471-2483.
5. Burke TW, Hoskins WJ, Heller PB, Bibro MC, Weiser EB, Park RC. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 1987;26:153-159.
6. Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer. 1990;65:2507-2514.
7. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with Stage IB cervical carcinoma. Gynecol Oncol. 1995;59:38-44.
8. Kjorstad KE, Bond B. Stage IB adenocarcinoma of the cervix: metastatic potential and patterns of dissemination. Am J Obstet Gynecol. 1984;150:297-299.
9. Harrison TA, Sevin BU, Koechli O, et al. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Gynecol Oncol. 1993;50:310-315.
10. Kjorstad KE. Adenocarcinoma of the uterine cervix. Gynecol Oncol. 1977;5:219-223.
11. Moberg PJ, Einhorn N, Silfversward C, Soderberg G. Adenocarcinoma of the uterine cervix. Cancer. 1986;57:407-410.
12. Gallup DG, Harper RH, Stock RJ. Poor prognosis in patients with adenosquamous cell carcinoma of the cervix. Obstet Gynecol. 1985;65:416-422.
13. Look KY, Brunetto VL, Clarke-Pearson DL, et al. An analysis of cell type in patients with surgically staged Stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1996;63:304-311.
14. Hopkins MP, Schmidt RW, Roberts JA, Morley GW. The prognosis and treatment of Stage I adenocarcinoma of the cervix. Obstet Gynecol. 1988;72:915-921.
15. Goodman HM, Buttlar CA, Niloff JM, et al. Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol. 1989;33:241-247.
16. Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JL Jr. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer. 1986;57:1584-1593.
17. Kleine W, Rau K, Schwoeorer D, Pfleiderer A. Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol. 1989;35:145-149.
18. Ishikawa H, Nakanishi T, Inoue T, Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol. 1999;73:42-46.
19. Eifel PJ, Burke TW, Delclos L, Wharton IT, Oswald MJ. Early Stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol. 1991;41:199-205.
20. Yazigi R, Sandstad J, Munoz AK, Choi DJ, Nguyen PD, Risser R. Adenosquamous carcinoma of the cervix: prognosis in Stage IB. Obstet Gynecol. 1990;75:1012-1015.
21. Kihana T, Tsuda H, Teshima S, et al. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix. Cancer. 1994;73:148-153.
22. Leung TW, Cheung AN, Cheng DK, Wong LC, Ngan HY. Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: correlation with clinical prognosis. Oncol Rep. 2001; 8:1159-1164.
23. Mandai M, Konishi I, Koshiyama M, et al. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix. Cancer. 1995;75:2523-2529.